Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease chronic lymphocytic leukemia
Phenotype C0040034|thrombocytopenia
Sentences 6
PubMedID- 23521128 Immune thrombocytopenia in patients with chronic lymphocytic leukemia treated with cladribine-based regiments or chlorambucil--follow-up of palg-cll randomized trials.
PubMedID- 23274356 Utilizing the database of the israeli cll study group, we investigated the prevalence and prognostic significance of anemia and thrombocytopenia in patients with chronic lymphocytic leukemia (cll).
PubMedID- 22718434 Low-dose alemtuzumab-associated immune thrombocytopenia in chronic lymphocytic leukemia.
PubMedID- 22322667 Purpose: to assess biologic features related to the development of immune thrombocytopenia (itp) in patients with chronic lymphocytic leukemia (cll).
PubMedID- 25702666 chronic lymphocytic leukemia (cll) may be associated with immune thrombocytopenia (itp).
PubMedID- 26501980 Since cd22 is a b-lymphocyte-restricted phosphoglycoprotein [184], inotuzumab ozogamicin has been clinically examined in b-cell leukemias and lymphomas with reversible thrombocytopenia as the main toxicity observed.

Page: 1